BR9407413A - Compostos uso dos mesmos e processo para a sua preparação composições farmacêuticas e processo para o tratamento de doenças - Google Patents
Compostos uso dos mesmos e processo para a sua preparação composições farmacêuticas e processo para o tratamento de doençasInfo
- Publication number
- BR9407413A BR9407413A BR9407413A BR9407413A BR9407413A BR 9407413 A BR9407413 A BR 9407413A BR 9407413 A BR9407413 A BR 9407413A BR 9407413 A BR9407413 A BR 9407413A BR 9407413 A BR9407413 A BR 9407413A
- Authority
- BR
- Brazil
- Prior art keywords
- disorders
- pct
- treatment
- methylene
- sec
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 2
- 201000010099 disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- 208000011117 substance-related disease Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 206010013654 Drug abuse Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000008238 Muscle Spasticity Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010033664 Panic attack Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 210000000607 neurosecretory system Anatomy 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 201000004240 prostatic hypertrophy Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 208000018198 spasticity Diseases 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939318431A GB9318431D0 (en) | 1993-09-06 | 1993-09-06 | Therapeutic agents |
| PCT/EP1994/002904 WO1995007274A1 (en) | 1993-09-06 | 1994-09-01 | Bicyclic aromatic compounds as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9407413A true BR9407413A (pt) | 1996-11-12 |
Family
ID=10741568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9407413A BR9407413A (pt) | 1993-09-06 | 1994-09-01 | Compostos uso dos mesmos e processo para a sua preparação composições farmacêuticas e processo para o tratamento de doenças |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5767116A (pt) |
| EP (1) | EP0717739B1 (pt) |
| JP (1) | JPH09502431A (pt) |
| KR (1) | KR100325964B1 (pt) |
| CN (1) | CN1052723C (pt) |
| AT (1) | ATE191214T1 (pt) |
| AU (1) | AU689802B2 (pt) |
| BG (1) | BG63272B1 (pt) |
| BR (1) | BR9407413A (pt) |
| CA (1) | CA2170056A1 (pt) |
| CZ (1) | CZ61496A3 (pt) |
| DE (1) | DE69423767T2 (pt) |
| DK (1) | DK0717739T3 (pt) |
| ES (1) | ES2144528T3 (pt) |
| FI (1) | FI961016A (pt) |
| GB (1) | GB9318431D0 (pt) |
| GR (1) | GR3033575T3 (pt) |
| HU (1) | HUT75875A (pt) |
| IL (1) | IL110844A (pt) |
| NO (1) | NO308536B1 (pt) |
| NZ (1) | NZ273581A (pt) |
| PL (1) | PL178270B1 (pt) |
| PT (1) | PT717739E (pt) |
| RO (1) | RO116811B1 (pt) |
| RU (1) | RU2136680C1 (pt) |
| SI (1) | SI9420058B (pt) |
| SK (1) | SK27196A3 (pt) |
| TW (1) | TW311137B (pt) |
| UA (1) | UA41952C2 (pt) |
| WO (1) | WO1995007274A1 (pt) |
| ZA (1) | ZA946798B (pt) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
| FR2738823B1 (fr) * | 1995-09-15 | 1997-10-31 | Synthelabo | Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique |
| GB9526495D0 (en) * | 1995-12-23 | 1996-02-28 | Knoll Ag | Therapeutic agents |
| DE19624154A1 (de) | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung |
| GB9627006D0 (en) * | 1996-12-27 | 1997-02-12 | Knoll Ag | Therapeutic agents |
| GB9627005D0 (en) * | 1996-12-27 | 1997-02-12 | Knoll Ag | Therapeutic agents |
| FR2760014B1 (fr) * | 1997-02-27 | 1999-04-09 | Adir | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9704948D0 (en) | 1997-03-11 | 1997-04-30 | Knoll Ag | Therapeutic agents |
| FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6077850A (en) | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
| US6034256A (en) | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
| GB9811879D0 (en) * | 1998-06-03 | 1998-07-29 | Knoll Ag | Therapeutic agents |
| FR2780057B1 (fr) * | 1998-06-18 | 2002-09-13 | Sanofi Sa | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2782515B1 (fr) * | 1998-08-21 | 2000-09-22 | Adir | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
| US6458804B1 (en) * | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
| US6656951B2 (en) * | 2001-04-24 | 2003-12-02 | Wyeth | 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists |
| US6656950B2 (en) | 2001-04-25 | 2003-12-02 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| DE10120619A1 (de) * | 2001-04-26 | 2002-10-31 | Merck Patent Gmbh | 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman |
| WO2002088129A1 (en) * | 2001-04-26 | 2002-11-07 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline |
| GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| US6667322B2 (en) | 2001-10-05 | 2003-12-23 | Wyeth | Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole |
| US6800637B2 (en) * | 2002-09-12 | 2004-10-05 | Wyeth | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| US6939877B2 (en) * | 2002-09-12 | 2005-09-06 | Wyeth | Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| US7153849B2 (en) * | 2002-09-12 | 2006-12-26 | Wyeth | Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans |
| US6911445B2 (en) * | 2002-09-12 | 2005-06-28 | Wyeth | Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| FR2884251B1 (fr) * | 2005-04-08 | 2007-07-13 | Servier Lab | Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1888548B1 (en) | 2005-05-26 | 2012-08-22 | Neuron Systems, Inc | Quinoline derivative for the treatment of retinal diseases |
| TWI457122B (zh) * | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物 |
| MX2018015872A (es) | 2016-06-29 | 2019-04-22 | Orion Corp | Derivados de benzodioxano y su uso farmaceutico. |
| CN117580569A (zh) * | 2021-07-02 | 2024-02-20 | 奥尔德拉医疗公司 | 杂环型醛捕获化合物和其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684739A (en) * | 1980-12-15 | 1987-08-04 | Mitsubishi Chemical Industries Limited | Alkylenedioxybenzene derivatives and acid addition salts thereof |
| JPS58154574A (ja) * | 1982-03-09 | 1983-09-14 | Mitsubishi Chem Ind Ltd | アルキレンジオキシベンゼン誘導体およびその酸付加塩 |
| US4569933A (en) * | 1984-04-13 | 1986-02-11 | Cornu Pierre Jean | Antihypertensive substituted derivatives of 2,5-diamino 1,4-diazole |
| CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
| US4749702A (en) * | 1985-04-15 | 1988-06-07 | Janssen Pharmaceutica N. V. | Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines |
| DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| FR2658823B1 (fr) * | 1990-02-27 | 1992-04-30 | Adir | Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent . |
| US5182292A (en) * | 1991-06-21 | 1993-01-26 | American Home Products Corporation | Psychotropic piperidinylmethyl benzodioxans |
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
-
1993
- 1993-09-06 GB GB939318431A patent/GB9318431D0/en active Pending
-
1994
- 1994-09-01 CZ CZ96614A patent/CZ61496A3/cs unknown
- 1994-09-01 KR KR1019960701111A patent/KR100325964B1/ko not_active IP Right Cessation
- 1994-09-01 AT AT94927531T patent/ATE191214T1/de not_active IP Right Cessation
- 1994-09-01 RU RU96113203A patent/RU2136680C1/ru active
- 1994-09-01 RO RO96-00406A patent/RO116811B1/ro unknown
- 1994-09-01 CN CN94193808A patent/CN1052723C/zh not_active Expired - Fee Related
- 1994-09-01 UA UA96041333A patent/UA41952C2/uk unknown
- 1994-09-01 ES ES94927531T patent/ES2144528T3/es not_active Expired - Lifetime
- 1994-09-01 SI SI9420058A patent/SI9420058B/sl unknown
- 1994-09-01 WO PCT/EP1994/002904 patent/WO1995007274A1/en not_active Application Discontinuation
- 1994-09-01 SK SK271-96A patent/SK27196A3/sk unknown
- 1994-09-01 PL PL94313347A patent/PL178270B1/pl unknown
- 1994-09-01 NZ NZ273581A patent/NZ273581A/en unknown
- 1994-09-01 US US08/605,130 patent/US5767116A/en not_active Expired - Lifetime
- 1994-09-01 DE DE69423767T patent/DE69423767T2/de not_active Expired - Fee Related
- 1994-09-01 JP JP7508440A patent/JPH09502431A/ja not_active Ceased
- 1994-09-01 AU AU76928/94A patent/AU689802B2/en not_active Ceased
- 1994-09-01 DK DK94927531T patent/DK0717739T3/da active
- 1994-09-01 PT PT94927531T patent/PT717739E/pt unknown
- 1994-09-01 CA CA002170056A patent/CA2170056A1/en not_active Abandoned
- 1994-09-01 BR BR9407413A patent/BR9407413A/pt not_active Application Discontinuation
- 1994-09-01 EP EP94927531A patent/EP0717739B1/en not_active Expired - Lifetime
- 1994-09-01 HU HU9600552A patent/HUT75875A/hu unknown
- 1994-09-02 IL IL11084494A patent/IL110844A/xx not_active IP Right Cessation
- 1994-09-05 ZA ZA946798A patent/ZA946798B/xx unknown
-
1995
- 1995-03-04 TW TW084102088A patent/TW311137B/zh active
-
1996
- 1996-02-29 BG BG100388A patent/BG63272B1/bg unknown
- 1996-03-05 NO NO960888A patent/NO308536B1/no not_active IP Right Cessation
- 1996-03-05 FI FI961016A patent/FI961016A/fi unknown
-
2000
- 2000-05-31 GR GR20000401270T patent/GR3033575T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9407413A (pt) | Compostos uso dos mesmos e processo para a sua preparação composições farmacêuticas e processo para o tratamento de doenças | |
| BR9609506A (pt) | Compostos composição uso dos compostos e processo para tratar depressao ansiedade psicoses discinésia tardia doença de parkinson hipertensão síndrome de tourette comportamento obsessivo-compulsivo ataques de pánico fobias sociais distúrbios cardiovasculares e cerebrovasculares estresse ou hipertrofia postática em seres humanos | |
| DE50307267D1 (de) | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| DK0626381T3 (da) | Fremstilling af form 1 ranitidinhydrochlorid | |
| NO993172L (no) | Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet | |
| EP0397044A3 (de) | Neue Arylsulfonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| AU667169B2 (en) | Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents | |
| BG102084A (en) | Condensed thiazole derivativs having affinity to 5-ht receptors | |
| BR1100306A (pt) | Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos | |
| WO2001072741A3 (en) | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds for the treatment of central nervous system disorders | |
| BR9910927A (pt) | Composto, composições farmacêuticas, processo para tratamento de depressão, ansiedade, psicoses, doença de parkinson, obesidade, hipertensão, sìndrome de tourette, disfunção sexual, toxicomania, abuso de droga, distúrbios cognitivos, doença de alzheimer, demência senil, comportamento obsessivo-compulsivo, ataques de pânico, indisposições alimentares, anorexia, distúrbios cardiovascular e cerebrovascular, enxaqueca, diabetes melitus não dependente de insulina, hiperglicemia, constipação, arritmia, distúrbios do sistema neuroendócrino, tensão, hipertrofia prostática, sintomas extrapiramidais induzidos por drogas ou espasticidade, uso de um composto, e, processo para preparação do composto | |
| FI956230A (fi) | beta-aminovinyyliketonit, valmistusmenetelmä sekä niiden käyttö beta-diketonien valmistukseen | |
| BR9707004A (pt) | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento | |
| Ye et al. | Synthesis of a New Tyrosine Analogue Having χ1 and χ2 Angles Constrained to Values Observed for an SH2 Domain-Bound Phosphotyrosyl Residue | |
| AR005368A1 (es) | Compuestos de heteroarilcarboxamidas, las composiciones farmaceuticas que los contienen, la aplicacion de dichos compuestos para la preparacion demedicamentos, un metodo para tratar enfermedades con dichos compuestos y los procedimientos para preparar dichos compuestos. | |
| RU2000133316A (ru) | N-бензодиоксанилметил-1-пиперидил-метиламины, обладающие сродством к рецепторам 5-нт | |
| DK0815109T3 (da) | Fremgangsmåde til fremstilling af estere af anhydroecgonin | |
| TH35654B (th) | 10- อะมิโนอลิฟาทิล-ไดเบนซ[b,f]ออกเซพีนที่มีการออกฤทธิ์ต่อต้านการเสื่อมของประสาท |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |